News

Fast-acting vaccine

Within 10 days after the first injection of the experimental coronavirus vaccine, the immune system produces a record number of antibodies.

Is your eyesight deteriorating? Play "shooting games"!

The experienced group played Unreal Tournament and Call of Duty 2 for 9 weeks, and the control group raised law-abiding citizens in Sims 2. In the second case, after 50 hours of games, no change in visual function was noted, but the masters of the rifle, laser and other flamethrowers had contrast vision improved by 0.16–0.20 logarithmic units, that is, by 43-58%.

UV Mask

A group of inventors from the Sverdlovsk region has come up with an electronic reusable mask that will protect doctors from coronavirus.

Yescarta made in Cina

Shanghai-based company Fosun Kite Biotechnology, a joint venture between China and the United States, will produce the drug Yescarta.

Gold, Silver and Bronze

MSU, St. Petersburg State University and NSU took the first three places in the list of the best higher education institutions in Eastern Europe.

The herpes virus will help in the creation of antiviral vaccines

Vitamin D: children – from rickets, old people – from dementia

The elderly, in whose body there was an increased content of vitamin D, are half as susceptible to impaired thinking processes. And when it is not enough, the probability of deterioration of attention and memory is also twice as high.

An unusual "valentine"

An Australian man received a kidney from his wife as a Valentine's Day gift.

It is not age that is to blame for senile hearing loss, but a gene

Old people don't have to be deaf. The genetic background of senile hearing loss has already been calculated. And even understand the mechanism of hearing destruction. Now doctors are starting to search for an effective medicine.

RUSNANO and leading scientific institutions of the country signed cooperation agreements

The documents were signed by Anatoly Chubais, CEO of RUSNANO, Yuri Osipov, President of the Russian Academy of Sciences, and Viktor Sadovnichy, Rector of Moscow State University.

CRISPR in Canada is owned by Merck

The Canadian Patent Office has granted a decision to grant Merck a patent for CRISPR technology.

Fifth Congress of the Society of Biotechnologists of Russia

On December 2-4, 2008, the Fifth Congress of the Ovchinnikov Society of Biotechnologists of Russia will be held in Moscow.

Pork for transplantologists

A major supplier of packaged meat products and pork producer in the United States plans to decellularize pork organs and sell them to medical institutions.

Patent for CRISPR in Europe

The European Patent Office intends to grant a patent with a wide scope of protection for the use of the popular genome editor – the CRISPR system – to the University of California.

Biohackers were recognized as dangerous to society

The possibility of experimenting with the genetic code at home creates a risk of organisms with undesirable properties, according to the British Council for Bioethics.

Gene therapy of Wiskott-Aldrich syndrome: the first successes

According to the data presented at the congress of the American Society of Hematology, four boys suffering from a rare hereditary disease had a significant improvement in their health after treatment.

Nanotubes + lysozyme = antimicrobial coating

Single-walled carbon nanotubes were able to absorb lysozyme and retain it for a time much longer than it takes for other antimicrobial surfaces to lose their bactericidal activity.

Sirtuins prolong life, but damage neurons

In some cases, overexpression of proteins of the sirtuins family (sirtuins, Sir2), known for their ability to slow down aging, causes oxidative damage to brain cells.

Lactobacilli will protect babies from HIV-infected breast milk

A group of researchers has identified a special strain of lactobacilli living in the human oral cavity. This type of bacteria captures HIV viruses by attaching them to its outer shell. Since these bacteria grow and multiply in milk, it is enough to vaccinate a baby once to provide him with protection from infection until the end of the breastfeeding period.

Stem fake: the investigation continues

A preliminary study of the drug "Stemamin" showed that its composition does not correspond to the formulation stated in the regulatory documentation. According to the expert opinion, this remedy does not contain living cells, since stem cells cannot live in any cosmetic forms.